Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.880
+0.040 (1.41%)
Sep 17, 2026, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 525.53 million as of September 16, 2026. Its market cap has increased by 7.67% in one year.
Market Cap
525.53M
Enterprise Value
837.51M
Revenue
736.15M
Ranking
n/a
PE Ratio
23.03
Stock Price
2.88
ChartMarket Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 525.53M, a decrease of -23.87%. That is a compound annual growth rate of -4.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 525.53M | 0.11% |
| Dec 31, 2025 | 524.97M | -23.31% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sonic Healthcare | 9.56B |
| Integral Diagnostics | 860.45M |
| Healius | 330.40M |
| Monash IVF Group | 294.17M |
| Cryosite | 57.60M |
| Microba Life Sciences | 37.82M |
| Rhythm Biosciences | 29.02M |
| BCAL Diagnostics | 26.18M |